📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. (2023)

First Author: Hua DY

Attributed to: Cannabidiol: a novel treatment for cannabis dependence? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41398-023-02410-9

PubMed Identifier: 37085531

Publication URI: http://europepmc.org/abstract/MED/37085531

Type: Journal Article/Review

Volume: 13

Parent Publication: Translational psychiatry

Issue: 1

ISSN: 2158-3188